Literature DB >> 27617837

Perceived Symptom Experience in Head and Neck Cancer Patients with Lymphedema.

Jie Deng1, Sheila Ridner1, Russell Rothman2, Barbara Murphy3, Kerry Sherman4, Lee Moore5, Kourtney Hall1, Betsy Weiner1.   

Abstract

BACKGROUND: Lymphedema frequently develops as a long-term effect from cancer and/or its treatment, including head and neck cancer (HNC). There is a substantial lack of understanding regarding the symptoms and experiences related to head and neck lymphedema.
OBJECTIVE: The objective of this study was to explore HNC patients' experiences of lymphedema, with emphasis on physical findings and associated symptom burden.
DESIGN: This was a qualitative, descriptive study. A purposive sample of 20 HNC patients who completed lymphedema therapy participated in semistructured, face-to-face interviews. Thematic content analysis was utilized to assess data.
RESULTS: Participants delineated the time when lymphedema onset presented and the sites of involvement. Most participants first noticed external or internal lymphedema/swelling within three months following either surgery or radiation therapy. Participants described a broad array of concurrent symptoms and functional deficits, including altered sensations, altered functions, neck-shoulder musculoskeletal/skin impairments, and psychosocial symptoms. DISCUSSION: HNC patients experienced multiple physical and psychosocial symptoms during the time they experienced lymphedema.
CONCLUSIONS: Clinicians need to inquire about tissue swelling and associated symptoms early in the post-treatment period to initiate lymphedema management strategies in a timely manner and facilitate reduction of long-term symptom burden and functional deficits.

Entities:  

Mesh:

Year:  2016        PMID: 27617837     DOI: 10.1089/jpm.2016.0174

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  6 in total

Review 1.  Symptom Clusters in Head and Neck Cancer: A Systematic Review and Conceptual Model.

Authors:  Asha Mathew; Amit Jiwan Tirkey; Hongjin Li; Alana Steffen; Mark B Lockwood; Crystal L Patil; Ardith Z Doorenbos
Journal:  Semin Oncol Nurs       Date:  2021-09-03       Impact factor: 3.527

2.  Patient experience of head and neck lymphedema therapy: a qualitative study.

Authors:  Jie Deng; Robert J Sinard; Barbara Murphy
Journal:  Support Care Cancer       Date:  2018-08-30       Impact factor: 3.603

3.  Lymphedema self-care in patients with head and neck cancer: a qualitative study.

Authors:  Jie Deng; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2016-08-10       Impact factor: 3.603

4.  Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.

Authors:  Dianne I Lou; Mary S Dietrich; Jie Deng; Barbara A Murphy
Journal:  Head Neck       Date:  2021-10-07       Impact factor: 3.821

5.  A Pre-clinical Animal Model of Secondary Head and Neck Lymphedema.

Authors:  Giulia Daneshgaran; Andrea Y Lo; Connie B Paik; Michael N Cooper; Cynthia Sung; Wan Jiao; Sun Y Park; Pauline Ni; Roy P Yu; Ivetta Vorobyova; Tea Jashashvili; Young-Kwon Hong; Gene H Kim; Peter S Conti; Yang Chai; Alex K Wong
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

6.  Longitudinal effects of a novel advanced pneumatic compression device on patient-reported outcomes in the management of cancer-related head and neck lymphedema: A preliminary report.

Authors:  Carolina Gutiérrez; Harvey N Mayrovitz; Syed Hassan Shiraz Naqvi; Ron J Karni
Journal:  Head Neck       Date:  2020-03-18       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.